scholarly journals Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

2017 ◽  
Vol 18 (10) ◽  
pp. 1411-1422 ◽  
Author(s):  
Marianne E Pavel ◽  
Simron Singh ◽  
Jonathan R Strosberg ◽  
Lida Bubuteishvili-Pacaud ◽  
Evgeny Degtyarev ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document